Trip.com Group Faces Securities Fraud Lawsuit Over Alleged Monopolistic Conduct

Trip.com Group Limited (NASDAQ: TCOM), the dominant force in China’s online travel agency (OTA) market, has been hit with a securities fraud class-action lawsuit that underscores the ongoing friction between Chinese platform giants and international disclosure requirements. The lawsuit, captioned De Wilde v. Trip.com Group Limited, et al., was filed in the United States District Court for the Eastern District of New York, alleging that the company and certain executives misled investors regarding the nature of its business operations and its exposure to regulatory risks associated with monopolistic practices.

The core of the litigation centers on the period between April 30, 2024, and January 13, 2026. During this window, the plaintiffs allege that Trip.com made materially false or misleading statements about its competitive standing and failed to disclose that it was engaging in monopolistic business activities. Such activities often draw the scrutiny of China’s State Administration for Market Regulation (SAMR), which has spent the last several years tightening the leash on 'platform economy' leaders to prevent unfair competition and price manipulation. For investors, the lack of transparency regarding these practices meant they were potentially buying into a risk profile that was far more volatile than the company’s public filings suggested.

“

Such activities often draw the scrutiny of China’s State Administration for Market Regulation (SAMR), which has spent the last several years tightening the leash on 'platform economy' leaders to prevent unfair competition and price manipulation.

The timing of the class period is particularly telling for market analysts. The January 13, 2026, cutoff date likely corresponds with a 'corrective disclosure'—an event where the previously concealed information becomes public, typically resulting in a sharp decline in share price. While the specific regulatory action or internal leak that occurred on that date has not been fully detailed in preliminary filings, the legal challenge suggests that the revelation significantly impacted the company’s valuation. This pattern is common among U.S.-listed Chinese firms (ADRs), which often find themselves caught between aggressive domestic growth strategies and the stringent transparency demands of the U.S. Securities and Exchange Commission (SEC).